Nexstim goes commercial with new funding
Medical technology company Nexstim is raising 1.75 million euros in equity financing via a directed issue of new shares to a UK-based fund.
FIT Biotech dives into genes with Avacta
FIT Biotech has initiated a research collaboration with UK-based Avacta Group to develop gene therapies combining the companies’ strengths.
Herantis Pharma lands Nordic Stars Award
Finnish Herantis Pharma was announced as the winner of the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden.
Herantis Pharma granted a US patent
The United States Patent and Trademark Office has issued a patent titled ‘Neurotrophic factor MANF and uses thereof’ to Finnish Herantis Pharma.
Helsinki institutions team up abroad for health
The Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki are collaborating with Pfizer and GlaxoSmithKline through new partner contracts.
FIT Biotech and InnaVirVax to fight HIV
Finnish FIT Biotech and Paris-based InnaVirVax have commenced collaboration in HIV treatment that combines their proprietary immunotherapeutic HIV vaccines.
Orion and US university partner up against cancer
Finnish pharmaceutical and diagnostics company Orion has announced a collaboration with a US non-profit organisation in pursuit of new medicines for oncological diseases.
Herantis bags EUR 6 million for Parkinson’s study
Finnish pharmaceutical company Herantis Pharma has received funding from the research and innovation program of the European Union known as Horizon 2020.
Finnish sea buckthorn opens eyes in Europe
Finnish Aromtech and Piiloset have developed a sea buckthorn oil for treating dry eyes. The product will be available first in Europe and later elsewhere in the world.
Faron advances cancer immunotherapy with new co-operation
Finnish biopharmaceutical company Faron Pharmaceuticals has entered into an agreement with Swiss-based life science company Selexis.